Inventor · disambiguated record
Richard D. Dimarchi
Also filed as: DIMARCHI RICHARD · DIMARCHI RICHARD D · DIMARCHI RICHARD DENNIS
111 granted patents·41 pending applications·4,241 citations·filing 1983–2023
99Inventor score
Files withLILLY CO ELI43UNIV INDIANA RES & TECH CORP40DIMARCHI RICHARD D27NOVO NORDISK AS9AMBRX INC7
Top patents by PatentIndex Score
152 records- 0198US8053560B2Modified human plasma polypeptide or Fc scaffolds and their usesAMBRX INC·Filed 2007·Granted Nov 8, 2011·40 cites·5 claims
- 0298US7919591B2Modified human plasma polypeptide or Fc scaffolds and their usesAMBRX INC·Filed 2007·Granted Apr 5, 2011·41 cites·1 claims
- 0398US6583111B1Use of GLP-1 analogs and derivative adminstered peripherally in regulation of obesityLILLY CO ELI·Filed 2000·Granted Jun 24, 2003·269 cites·31 claims
- 0498US6191102B1Use of GLP-1 analogs and derivatives administered peripherally in regulation of obesityLILLY CO ELI·Filed 1997·Granted Feb 20, 2001·412 cites·20 claims
- 0597US7211557B2Use of GLP-1 analogs and derivatives administered peripherally in regulation of obesityLILLY CO ELI·Filed 2003·Granted May 1, 2007·107 cites·8 claims
- 0697US5514646AInsulin analogs modified at position 29 of the B chainFiled 1993·Granted May 7, 1996·256 cites·81 claims
- 0797US5512549AGlucagon-like insulinotropic peptide analogs, compositions, and methods of useLILLY CO ELI·Filed 1994·Granted Apr 30, 1996·449 cites·28 claims
- 0896US8618257B2Modified human plasma polypeptide or Fc scaffolds and their usesSHEFFER JOSEPH·Filed 2007·Granted Dec 31, 2013·32 cites·4 claims
- 0996US8022186B2Modified human plasma polypeptide or Fc scaffolds and their usesAMBRX INC·Filed 2007·Granted Sep 20, 2011·20 cites·5 claims
- 1096US5552524AAnti-obesity proteinsLILLY CO ELI·Filed 1995·Granted Sep 3, 1996·172 cites·15 claims
- 1195US8778880B2Human growth hormone modified at position 35CHO HO SUNG·Filed 2005·Granted Jul 15, 2014·25 cites·5 claims
- 1295US8729017B2Glucagon/GLP-1 receptor co-agonistsDIMARCHI RICHARD D·Filed 2012·Granted May 20, 2014·29 cites·23 claims
- 1395US7238663B2Pre-mixes of GLP-1 and basal insulinLILLY CO ELI·Filed 2002·Granted Jul 3, 2007·103 cites·3 claims
- 1495US7199217B2Amidated glucagon-like peptide-1LILLY CO ELI·Filed 2001·Granted Apr 3, 2007·65 cites·1 claims
- 1595US5521283AAnti-obesity proteinsLILLY CO ELI·Filed 1995·Granted May 28, 1996·147 cites·8 claims
- 1694US8450270B2Glucagon analogs exhibiting enhanced solubility and stability in physiological pH buffersDIMARCHI RICHARD D·Filed 2009·Granted May 28, 2013·37 cites·16 claims
- 1794US7939496B2Modified human growth horomone polypeptides and their usesAMBRX INC·Filed 2005·Granted May 10, 2011·25 cites·4 claims
- 1894US7179788B2Biphasic mixtures of GLP-1 and insulinLILLY CO ELI·Filed 2002·Granted Feb 20, 2007·94 cites·6 claims
- 1994US5552523AAnti-obesity proteinsLILLY CO ELI·Filed 1995·Granted Sep 3, 1996·124 cites·15 claims
- 2093US8703701B2Glucagon/GLP-1 receptor co-agonistsDIMARCHI RICHARD D·Filed 2010·Granted Apr 22, 2014·23 cites·15 claims
- 2193US8507428B2Glucagon analogs exhibiting GIP receptor activityDIMARCHI RICHARD D·Filed 2011·Granted Aug 13, 2013·24 cites·11 claims
- 2293US5700662AProcess for preparing insulin analogsLILLY CO ELI·Filed 1995·Granted Dec 23, 1997·101 cites·20 claims
- 2392US9018164B2Glucagon analogs exhibiting physiological solubility and stabilityDIMARCHI RICHARD D·Filed 2012·Granted Apr 28, 2015·16 cites·19 claims
- 2492US8975223B2Methods for treating metabolic disorders and obesity with a peptide comprising the amino acid sequence of SEQ ID No. 146VIGNATI LOUIS·Filed 2011·Granted Mar 10, 2015·38 cites·11 claims
- 2592US8778872B2Amide based glucagon superfamily peptide prodrugsDIMARCHI RICHARD D·Filed 2011·Granted Jul 15, 2014·34 cites·25 claims
- 2692US8551946B2Glucagon antagonist-GIP agonist conjugates and compositions for the treatment of metabolic disorders and obesityDIMARCHI RICHARD D·Filed 2011·Granted Oct 8, 2013·17 cites·17 claims
- 2792US8546327B2Glucagon/GLP-1 receptor co-agonistsDIMARCHI RICHARD D·Filed 2009·Granted Oct 1, 2013·26 cites·20 claims
- 2892US8338368B2Glucagon analogs exhibiting physiological solubility and stabilityDIMARCHI RICHARD D·Filed 2006·Granted Dec 25, 2012·18 cites·15 claims
- 2992US8143216B2Modified human growth hormoneCHO HO SUNG·Filed 2007·Granted Mar 27, 2012·17 cites·4 claims
- 3092US5552522AAnti-obesity proteinsLILLY CO ELI·Filed 1995·Granted Sep 3, 1996·116 cites·17 claims
- 3192US5304473AA-C-B proinsulin, method of manufacturing and using same, and intermediates in insulin productionLILLY CO ELI·Filed 1991·Granted Apr 19, 1994·120 cites·41 claims
- 3291US8981047B2Glucagon antagonistsDIMARCHI RICHARD D·Filed 2008·Granted Mar 17, 2015·15 cites·23 claims
- 3391US8900593B2Glucagon/GLP-1 receptor co-agonistsUNIV INDIANA RES & TECH CORP·Filed 2013·Granted Dec 2, 2014·16 cites·8 claims
- 3491US8454971B2Glucagon/GLP-1 receptor co-agonistsDAY JONATHAN·Filed 2008·Granted Jun 4, 2013·31 cites·8 claims
- 3591US5691309AAnti-obesity proteinsLILLY CO ELI·Filed 1995·Granted Nov 25, 1997·83 cites·21 claims
- 3691US5532336AAnti-obesity proteinsLILLY CO ELI·Filed 1995·Granted Jul 2, 1996·76 cites·17 claims
- 3789US8969288B2Amide based glucagon and superfamily peptide prodrugsDIMARCHI RICHARD D·Filed 2009·Granted Mar 3, 2015·17 cites·29 claims
- 3889US8697838B2Ester-based insulin prodrugsDIMARCHI RICHARD D·Filed 2010·Granted Apr 15, 2014·19 cites·19 claims
- 3989US8669228B2Glucagon analogs exhibiting enhanced solubility in physiological pH buffersDIMARCHI RICHARD D·Filed 2008·Granted Mar 11, 2014·16 cites·18 claims
- 4088US7557183B2Polyethylene glycol linked GLP-1 compoundsLILLY CO ELI·Filed 2004·Granted Jul 7, 2009·36 cites·10 claims
- 4187US9156902B2Glucagon/GLP-1 receptor co-agonistsDIMARCHI RICHARD D·Filed 2012·Granted Oct 13, 2015·6 cites·28 claims
- 4286US8980830B2Peptide compounds exhibiting glucagon antagonist and GLP-1 agonist activityDIMARCHI RICHARD D·Filed 2008·Granted Mar 17, 2015·15 cites·22 claims
- 4386US8969294B2Glucagon/GLP-1 receptor co-agonistsBIANCHI ELISABETTA·Filed 2012·Granted Mar 3, 2015·14 cites·12 claims
- 4486US8907064B2Modified human four helical bundle polypeptides and their usesCHO HO SUNG·Filed 2007·Granted Dec 9, 2014·5 cites·18 claims
- 4585US5719266AAnti-obesity proteinsLILLY CO ELI·Filed 1995·Granted Feb 17, 1998·70 cites·13 claims
- 4684US10730923B2Glucagon/GLP-1 receptor co-agonistsUNIV INDIANA RES & TECH CORP·Filed 2019·Granted Aug 4, 2020·2 cites·19 claims
- 4784US10604555B2GIP derivatives and uses thereofNOVO NORDISK AS·Filed 2019·Granted Mar 31, 2020·5 cites·30 claims
- 4884US10232020B2Incretin-insulin conjugatesUNIV INDIANA RES & TECH CORP·Filed 2015·Granted Mar 19, 2019·6 cites·19 claims
- 4983US9587005B2Glucagon analogs exhibiting GIP receptor activityUNIV INDIANA RES & TECH CORP·Filed 2015·Granted Mar 7, 2017·3 cites·18 claims
- 5083US9573987B2CTP-based insulin analogs for treatment of diabetesUNIV INDIANA RES & TECH CORP·Filed 2012·Granted Feb 21, 2017·5 cites·7 claims
Showing the top 50 of 152 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →